Cargando…

The Crucial Role of NLRP3 Inflammasome in Viral Infection-Associated Fibrosing Interstitial Lung Diseases

Idiopathic pulmonary fibrosis (IPF), one of the most common fibrosing interstitial lung diseases (ILD), is a chronic-age-related respiratory disease that rises from repeated micro-injury of the alveolar epithelium. Environmental influences, intrinsic factors, genetic and epigenetic risk factors that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Effendi, Wiwin Is, Nagano, Tatsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509020/ https://www.ncbi.nlm.nih.gov/pubmed/34638790 http://dx.doi.org/10.3390/ijms221910447

Ejemplares similares

Immunoregulatory Property of C-Type Lectin-Like Receptors in Fibrosing Interstitial Lung Diseases
por: Effendi, Wiwin Is, et al.
Publicado: (2020)

A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression
por: Effendi, Wiwin Is, et al.
Publicado: (2023)

The Role of Radiology in Progressive Fibrosing Interstitial Lung Disease
por: Abu Qubo, Ahmad, et al.
Publicado: (2022)

Role of imaging in progressive-fibrosing interstitial lung diseases
por: Walsh, Simon L.F., et al.
Publicado: (2018)

Progression of fibrosing interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020)

Management of Fibrosing Interstitial Lung Diseases
por: Maher, Toby M., et al.
Publicado: (2019)

The Hedgehog Signaling Pathway in Idiopathic Pulmonary Fibrosis: Resurrection Time
por: Effendi, Wiwin Is, et al.
Publicado: (2021)

Connective Tissue Growth Factor in Idiopathic Pulmonary Fibrosis: Breaking the Bridge
por: Effendi, Wiwin Is, et al.
Publicado: (2022)

Epigenetics Approaches toward Precision Medicine for Idiopathic Pulmonary Fibrosis: Focus on DNA Methylation
por: Effendi, Wiwin Is, et al.
Publicado: (2023)

The NLRP3 inflammasome in viral infection (Review)
por: Zheng, Qiaoli, et al.
Publicado: (2023)

The Burden of Progressive-Fibrosing Interstitial Lung Diseases
por: Cottin, Vincent, et al.
Publicado: (2022)

Management of patients with fibrosing interstitial lung diseases
por: Morrow, Lee E, et al.
Publicado: (2021)

Fibrosing interstitial lung diseases: knowns and unknowns
por: Cottin, Vincent, et al.
Publicado: (2019)

Crucial Role of NLRP3 Inflammasome in the Development of Peritoneal Dialysis-related Peritoneal Fibrosis
por: Hishida, Erika, et al.
Publicado: (2019)

The natural history of progressive fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2019)

The natural history of progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2020)

Management and support of patients with fibrosing interstitial lung diseases
por: Barbera, Tyonn, et al.
Publicado: (2021)

Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases
por: Chen, Xianqiu, et al.
Publicado: (2021)

Acute exacerbations of progressive-fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2018)

Nintedanib in children and adolescents with fibrosing interstitial lung diseases
por: Deterding, Robin, et al.
Publicado: (2023)

Burden of illness in progressive fibrosing interstitial lung disease
por: Singer, David, et al.
Publicado: (2022)

Targeting the NLRP3 inflammasome and associated cytokines in scleroderma associated interstitial lung disease
por: Woo, Samuel, et al.
Publicado: (2023)

Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases
por: Effendi, Wiwin Is, et al.
Publicado: (2020)

Role of NLRP3 inflammasome in the development of bladder pain syndrome interstitial cystitis
por: Tudrej, Karol Borys, et al.
Publicado: (2019)

Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
por: Cottin, Vincent
Publicado: (2019)

Diffuse pulmonary ossification associated with fibrosing interstitial lung disease
por: Alami, Badreeddine, et al.
Publicado: (2019)

Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
por: Wollin, Lutz, et al.
Publicado: (2019)

Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
por: Cottin, Vincent, et al.
Publicado: (2021)

Progressive fibrosing interstitial lung disease: prevalence and clinical outcome
por: Kwon, Byoung Soo, et al.
Publicado: (2021)

Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
por: Copeland, Carla R., et al.
Publicado: (2021)

Progressive Fibrosing Interstitial Lung Diseases: A Current Perspective
por: Albera, Carlo, et al.
Publicado: (2021)

Challenges in the Diagnosis and Management of Patients with Fibrosing Interstitial Lung Disease
por: Tolle, Leslie B.
Publicado: (2022)

Real-life prevalence of progressive fibrosing interstitial lung diseases
por: Gagliardi, Maureen, et al.
Publicado: (2021)

Interrelation Between Fibroblasts and T Cells in Fibrosing Interstitial Lung Diseases
por: Lai, Yunxin, et al.
Publicado: (2021)

Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2022)

Diagnostic and prognostic biomarkers for progressive fibrosing interstitial lung disease
por: Watase, Mayuko, et al.
Publicado: (2023)

Cluster features in fibrosing interstitial lung disease and associations with prognosis
por: Wang, Yuanying, et al.
Publicado: (2023)

Candidalysin Crucially Contributes to Nlrp3 Inflammasome Activation by Candida albicans Hyphae
por: Rogiers, Ona, et al.
Publicado: (2019)

Role of the Nlrp3 Inflammasome in Microbial Infection
por: Anand, Paras K., et al.
Publicado: (2011)

The Role of NLRP3 Inflammasome in Pneumococcal Infections
por: Surabhi, Surabhi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5f4cuj4b82o9gidoi5o92sva2n